AIM: The objective of the present study was to determine whether or not maternal metabolic syndrome in early pregnancy in women without previous diabetes is associated with the development of gestational diabetes mellitus (GDM). METHODS: A total of 508 women from the Rhea study-involving a pregnant cohort in Crete, Greece (2007-2009)-with singleton pregnancies were included in the present analysis. Maternal fasting serum samples were collected and blood pressure measured before gestational week 15. The metabolic syndrome in early pregnancy was defined according to NHLBI/AHA criteria. Pregnant women were screened for GDM between weeks 24 and 28 of gestation, as defined by Carpenter and Coustan criteria. Multivariable log-binomial regression models were used to estimate the effect of the metabolic syndrome in early pregnancy on the risk of GDM, after adjusting for confounding factors. RESULTS: Women with the metabolic syndrome were at high risk of GDM (RR=3.17; 95% CI: 1.06-9.50). Among the components of the metabolic syndrome, the most significant risk factors were impaired fasting glucose (RR=4.92; 95% CI: 1.41-17.23) and pre-pregnancy obesity (RR=2.65; 95% CI: 1.23-5.70). A 10-mmHg rise in systolic and diastolic blood pressure increased the relative risk of GDM by 49% (RR=1.49; 95% CI: 1.10-2.02) and 34% (RR=1.34; 95% CI: 1.04-1.73), respectively, whereas a 1-unit increase in pre-pregnancy BMI increased the relative risk of GDM by 6% (RR=1.06; 95% CI: 1.01-1.12). CONCLUSION: These findings suggest that women with the metabolic syndrome in early pregnancy have a greater risk of developing GDM.
AIM: The objective of the present study was to determine whether or not maternal metabolic syndrome in early pregnancy in women without previous diabetes is associated with the development of gestational diabetes mellitus (GDM). METHODS: A total of 508 women from the Rhea study-involving a pregnant cohort in Crete, Greece (2007-2009)-with singleton pregnancies were included in the present analysis. Maternal fasting serum samples were collected and blood pressure measured before gestational week 15. The metabolic syndrome in early pregnancy was defined according to NHLBI/AHA criteria. Pregnant women were screened for GDM between weeks 24 and 28 of gestation, as defined by Carpenter and Coustan criteria. Multivariable log-binomial regression models were used to estimate the effect of the metabolic syndrome in early pregnancy on the risk of GDM, after adjusting for confounding factors. RESULTS:Women with the metabolic syndrome were at high risk of GDM (RR=3.17; 95% CI: 1.06-9.50). Among the components of the metabolic syndrome, the most significant risk factors were impaired fasting glucose (RR=4.92; 95% CI: 1.41-17.23) and pre-pregnancy obesity (RR=2.65; 95% CI: 1.23-5.70). A 10-mmHg rise in systolic and diastolic blood pressure increased the relative risk of GDM by 49% (RR=1.49; 95% CI: 1.10-2.02) and 34% (RR=1.34; 95% CI: 1.04-1.73), respectively, whereas a 1-unit increase in pre-pregnancy BMI increased the relative risk of GDM by 6% (RR=1.06; 95% CI: 1.01-1.12). CONCLUSION: These findings suggest that women with the metabolic syndrome in early pregnancy have a greater risk of developing GDM.
Authors: K Koutra; M Vassilaki; V Georgiou; A Koutis; P Bitsios; M Kogevinas; L Chatzi Journal: Epidemiol Psychiatr Sci Date: 2016-12-22 Impact factor: 6.892
Authors: Daniel A Enquobahrie; Amy Moore; Seid Muhie; Mahlet G Tadesse; Shili Lin; Michelle A Williams Journal: Reprod Sci Date: 2015-02-11 Impact factor: 3.060
Authors: Nam H Cho; Chang Ho Ahn; Joon Ho Moon; Soo Heon Kwak; Sung Hee Choi; Soo Lim; Kyong Soo Park; Boyd E Metzger; Hak C Jang Journal: Medicine (Baltimore) Date: 2016-08 Impact factor: 1.889
Authors: Leslie Thomas Stayner; Marie Pedersen; Evridiki Patelarou; Ilse Decordier; Kim Vande Loock; Leda Chatzi; Ana Espinosa; Eleni Fthenou; Mark J Nieuwenhuijsen; Esther Gracia-Lavedan; Euripides G Stephanou; Micheline Kirsch-Volders; Manolis Kogevinas Journal: Environ Health Perspect Date: 2013-11-01 Impact factor: 9.031
Authors: Hamilton Dos Prazeres Tavares; Débora Cristina Damasceno Meirelles Dos Santos; Joelcio Francisco Abbade; Carlos Antonio Negrato; Paulo Adão de Campos; Iracema Mattos Paranhos Calderon; Marilza Vieira Cunha Rudge Journal: Diabetol Metab Syndr Date: 2016-03-22 Impact factor: 3.320
Authors: Emilyn U Alejandro; Therriz P Mamerto; Grace Chung; Adrian Villavieja; Nawirah Lumna Gaus; Elizabeth Morgan; Maria Ruth B Pineda-Cortel Journal: Int J Mol Sci Date: 2020-07-15 Impact factor: 5.923